BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19811546)

  • 21. Vas deferens, a site of male contraception: an overview.
    Lohiya NK; Manivannan B; Mishra PK; Pathak N
    Asian J Androl; 2001 Jun; 3(2):87-95. PubMed ID: 11404791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-controlled injectable occlusion of the vas deferens.
    Guha SK; Anand S; Ansari S; Farooq A; Sharma DN
    Contraception; 1990 Mar; 41(3):323-31. PubMed ID: 2323220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sites of residual spermatozoa after irrigation of the distal vas deferens using normal saline solution during vasectomy in a rat model.
    Sukapiriya C; Chanpalakorn N; Chalermsanyakorn P; Leungwattanakij S
    Int J Androl; 2005 Aug; 28(4):230-3. PubMed ID: 16048635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological changes in the vas deferens of rats after injection of a new male antifertility agent "SMA" and its reversibility.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1990 Mar; 41(3):333-9. PubMed ID: 2323221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive.
    Chaudhury K; Bhattacharyya AK; Guha SK
    Hum Reprod; 2004 Aug; 19(8):1826-30. PubMed ID: 15192063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological observations of vas deferens occlusion by the percutaneous injection of medical polyurethane.
    Chen Z; Gu Y; Liang X; Shen L; Zou W
    Contraception; 1996 May; 53(5):275-9. PubMed ID: 8724616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphological changes of spermatozoa in proximal vas deferens after vasectomy.
    Wen RQ; Li SQ; Wang CX; Wang QH; Liu MY
    Asian J Androl; 1999 Jun; 1(1-2):61-5. PubMed ID: 11225906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of URYX for reversible vasectomy in a rabbit model.
    Naughton CK; Myles J; Thomas AJ
    J Androl; 2004; 25(4):545-53. PubMed ID: 15223843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive.
    Verma K; Misro MM; Singh H; Mahajan S; Ray AR; Guha SK
    J Reprod Fertil; 1981 Nov; 63(2):539-42. PubMed ID: 7299756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
    Lohiya NK; Manivannan B; Mishra PK; Pathak N; Balasubramanian SP
    Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
    Singh AK
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicity and Mutagenicity Evaluation Following RISUG Contraception Reversal in Rats.
    Ansari AS; Hussain M; Khan SR; Badar A; Lohiya NK
    Int J Toxicol; 2018 Nov; ():1091581818809473. PubMed ID: 30380967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Failure following fertility vasectomy].
    Mellin HE; Bauer HW; Rattenhuber U
    Med Welt; 1980 Nov; 31(47):1723-4. PubMed ID: 7464522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the contractile activity of the male genital tract as a consequence of vasectomy.
    Hib J
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):159-65. PubMed ID: 3188959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and use of surgical procedures to bypass selected regions of the mammalian epididymis: effects on sperm maturation.
    Temple-Smith PD; Zheng SS; Kadioglu T; Southwick GJ
    J Reprod Fertil Suppl; 1998; 53():183-95. PubMed ID: 10645277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term toxicity studies of styrene maleic anhydride in rats.
    Sethi N; Srivastava RK; Singh RK; Nath D
    Biomed Environ Sci; 1990 Dec; 3(4):452-7. PubMed ID: 2096850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RISUG: a potential candidate for the entry inhibitor group of antiretroviral drugs.
    Banerjee S; Guha SK
    Med Hypotheses; 2009 Aug; 73(2):150-2. PubMed ID: 19409721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasectomy and its reversal.
    Belker AM
    Prim Care; 1985 Dec; 12(4):703-17. PubMed ID: 3853238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.